# VIVID - Valvular and Ventricular Improvement Via iCoapsys Delivery - Feasibility Study

> **NCT00512005** · PHASE1 · UNKNOWN · sponsor: **Myocor** · enrollment: 30 (estimated)

## Conditions studied

- Mitral Valve Regurgitation
- Left Ventricular Dysfunction
- Heart Failure
- Mitral Insufficiency
- Mitral Incompetence
- Ischemic Heart Disease

## Interventions

- **DEVICE:** Percutaneous mitral valve repair

## Key facts

- **NCT ID:** NCT00512005
- **Lead sponsor:** Myocor
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-01
- **Primary completion:** 2009-12
- **Final completion:** 2013-12
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2009-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00512005

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00512005, "VIVID - Valvular and Ventricular Improvement Via iCoapsys Delivery - Feasibility Study". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT00512005. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*